Profiel
Andre Marziali was the founder and former President & Chief Scientific Officer of Boreal Genomics, Inc. which was founded in 2007.
He was also an Assistant Professor at the University of British Columbia from 1998 to 2013.
Marziali earned his doctorate degree from Stanford University in 1994 and his undergraduate degree from the University of British Columbia in 1989.
Eerdere bekende functies van Andre Marziali
| Bedrijven | Functie | Einde |
|---|---|---|
| University of British Columbia | Corporate Officer/Principal | - |
Boreal Genomics, Inc.
 Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Boreal Genomics, Inc. develops and markets DNA and RNA purification, enrichment, and detection equipment and tools. It provides research tools and developing diagnostic tests based on non invasive tumor profiling and monitoring of cancer. The company’s OnTarget platform performs sensitive genomic analysis of cell free DNA in plasma to detect and quantify mutations in tumor derived circulating nucleic acids. The company was founded by Andre Marziali, Jason Donald Thompson, Joel Pel and David J. Broemeling in 2007 and is headquartered in Vancouver, Canada. | Oprichter | - |
Opleiding van Andre Marziali
| University of British Columbia | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Boreal Genomics, Inc.
Boreal Genomics, Inc. Medical SpecialtiesHealth Technology Boreal Genomics, Inc. develops and markets DNA and RNA purification, enrichment, and detection equipment and tools. It provides research tools and developing diagnostic tests based on non invasive tumor profiling and monitoring of cancer. The company’s OnTarget platform performs sensitive genomic analysis of cell free DNA in plasma to detect and quantify mutations in tumor derived circulating nucleic acids. The company was founded by Andre Marziali, Jason Donald Thompson, Joel Pel and David J. Broemeling in 2007 and is headquartered in Vancouver, Canada. | Health Technology |